XML 22 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Changes in Equity and Income - USD ($)
$ in Thousands
Total
Total Stockholders’ Equity
Common Stock
Capital in Excess of Par
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non-controlling Interests
Beginning balance (in shares) at Dec. 31, 2020     134,850,000        
Beginning balance at Dec. 31, 2020 $ 1,252,973 $ 1,060,480 $ 135 $ 509,128 $ 553,244 $ (2,027) $ 192,493
Increase (Decrease) in Stockholders' Equity              
Net income attributable to Select Medical Holdings Corporation 402,225 402,225     402,225    
Net income attributable to non-controlling interests 47,571 0         47,571
Cash dividends declared for common stockholders (50,600) (50,600)     (50,600)    
Issuance of restricted stock (in shares)     1,363,000        
Issuance of restricted stock 0 0 $ 1 (1)      
Forfeitures of unvested restricted stock (in shares)     (18,000)        
Forfeitures of unvested restricted stock 0 0 $ 0 0      
Vesting of restricted stock 28,798 28,798   28,798      
Repurchase of common shares (in shares)     (2,311,000)        
Repurchase of common shares (79,476) (79,476) $ (2) (33,322) (46,152)    
Issuance of non-controlling interests 21,186 3,646   3,646     17,540
Non-controlling interests acquired in business combination, measurement period adjustment 11,153 0         11,153
Distributions to and purchases of non-controlling interests (72,158) (19,197)   (3,757) (15,440)   (52,961)
Redemption value adjustment on non-controlling interests (250,083) (250,083)     (250,083)    
Other comprehensive income 14,309 14,309       14,309  
Other 4 (121)   (178) 57   125
Ending balance (in shares) at Dec. 31, 2021     133,884,000        
Ending balance at Dec. 31, 2021 1,325,902 1,109,981 $ 134 504,314 593,251 12,282 215,921
Increase (Decrease) in Stockholders' Equity              
Net income attributable to Select Medical Holdings Corporation 158,994 158,994     158,994    
Net income attributable to non-controlling interests 31,460 0         31,460
Cash dividends declared for common stockholders (64,589) (64,589)     (64,589)    
Issuance of restricted stock (in shares)     1,642,000        
Issuance of restricted stock 0 0 $ 1 (1)      
Forfeitures of unvested restricted stock (in shares)     (98,000)        
Forfeitures of unvested restricted stock 64 64 $ 0 0 64    
Vesting of restricted stock 35,550 35,550   35,550      
Repurchase of common shares (in shares)     (8,255,000)        
Repurchase of common shares (195,528) (195,528) $ (8) (87,838) (107,682)    
Issuance of non-controlling interests 10,170 665   665     9,505
Non-controlling interests acquired in business combination, measurement period adjustment 12,463 0         12,463
Distributions to and purchases of non-controlling interests (37,664) (2,957)   (507) (2,450)   (34,707)
Redemption value adjustment on non-controlling interests 3,385 3,385     3,385    
Other comprehensive income 76,320 76,320       76,320  
Other $ 37 37     37    
Ending balance (in shares) at Dec. 31, 2022 127,173,871   127,173,000        
Ending balance at Dec. 31, 2022 $ 1,356,564 1,121,922 $ 127 452,183 581,010 88,602 234,642
Increase (Decrease) in Stockholders' Equity              
Net income attributable to Select Medical Holdings Corporation 243,491 243,491     243,491    
Net income attributable to non-controlling interests 48,153 0         48,153
Cash dividends declared for common stockholders (63,904) (63,904)     (63,904)    
Issuance of restricted stock (in shares)     1,651,000        
Issuance of restricted stock 0 0 $ 1 (1)      
Forfeitures of unvested restricted stock (in shares)     (12,000)        
Forfeitures of unvested restricted stock 12 12 $ 0 0 12    
Vesting of restricted stock 43,619 43,619   43,619      
Repurchase of common shares (in shares)     (443,000)        
Repurchase of common shares (12,759) (12,759) $ 0 (5,184) (7,575)    
Issuance of non-controlling interests 23,051 1,870   1,870     21,181
Non-controlling interests acquired in business combination, measurement period adjustment 9,007 0         9,007
Distributions to and purchases of non-controlling interests (55,314) (1,745)   927 (2,672)   (53,569)
Redemption value adjustment on non-controlling interests 1,527 1,527     1,527    
Other comprehensive income (45,695) (45,695)       (45,695)  
Other $ (34) (34)   (1) (33)    
Ending balance (in shares) at Dec. 31, 2023 128,369,492   128,369,000        
Ending balance at Dec. 31, 2023 $ 1,547,718 $ 1,288,304 $ 128 $ 493,413 $ 751,856 $ 42,907 $ 259,414